P2X7 receptor and macrophage function
- 13 February 2009
- journal article
- research article
- Published by Springer Nature in Purinergic Signalling
- Vol. 5 (2) , 189-195
- https://doi.org/10.1007/s11302-009-9131-9
Abstract
Macrophages are unique innate immune cells that play an integral role in the defense of the host by virtue of their ability to recognize, engulf, and kill pathogens while sending out danger signals via cytokines to recruit and activate inflammatory cells. It is becoming increasingly clear that purinergic signaling events are essential components of the macrophage response to pathogen challenges and disorders such as sepsis may be, at least in part, regulated by these important sensors. The activation of the P2X7 receptor is a powerful event in the regulation of the caspase-1 inflammasome. We provide evidence that the inflammasome activation requires “priming” of macrophages prior to ATP activation of the P2X7R. Inhibition of the inflammasome activation by the tyrosine kinase inhibitor, AG126, suggests regulation by phosphorylation. Finally, the P2X7R may also be activated by other elements of the host response such as the antimicrobial peptide LL-37, which adds a new, physiologically relevant agonist to the P2X7R pathway. Therapeutic approaches to inflammation and sepsis will certainly be enhanced by an increased understanding of how purinergic receptors modulate the inflammasomes.Keywords
This publication has 44 references indexed in Scilit:
- Inhibition of the human P2X7 receptor by a novel protein tyrosine kinase antagonistBiochemical and Biophysical Research Communications, 2008
- Caspase-1 RegulatesEscherichia coliSepsis and Splenic B Cell Apoptosis Independently of Interleukin-1β and Interleukin-18American Journal of Respiratory and Critical Care Medicine, 2006
- Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptorThe EMBO Journal, 2006
- Cryopyrin activates the inflammasome in response to toxins and ATPNature, 2006
- Induction of Direct Antimicrobial Activity Through Mammalian Toll-Like ReceptorsScience, 2001
- ATP-stimulated Release of Interleukin (IL)-1β and IL-18 Requires Priming by Lipopolysaccharide and Is Independent of Caspase-1 CleavageJournal of Biological Chemistry, 2001
- The Tyrosine Kinase Inhibitor Tyrphostin AG126 Reduces the Development of Acute and Chronic InflammationThe American Journal of Pathology, 2000
- Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37Journal of Biological Chemistry, 1998
- Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase InhibitorsScience, 1994
- Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.Journal of Clinical Investigation, 1984